Atai Therapeutics, Inc.
πΊπΈUnited States
Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- atai Therapeutics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06693609
- Locations
- π¬π§
MAC Clinical Research - South Staffordshire, Bridgetown, Cannock, Staffordshire, United Kingdom
π¬π§MAC Clinical Research - Greater Manchester, Manchester, Greater Manchester, United Kingdom
π¬π§MAC Clinical Research - Lancashire, Blackpool, Lancashire, United Kingdom
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Phase 2
Recruiting
- Conditions
- Treatment Resistant Depression
- Interventions
- Drug: VLS-01-BU Placebo
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- atai Therapeutics, Inc.
- Target Recruit Count
- 142
- Registration Number
- NCT06524830
- Locations
- π¨π¦
Centre for Neurology Studies, Surrey, British Columbia, Canada
πΊπΈWoodland Research Northwest, Rogers, Arkansas, United States
πΊπΈCollaborative Neuroscience Research, LLC, Los Alamitos, California, United States
A Study of Oral Ibogaine in Opioid Withdrawal
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- atai Therapeutics, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT05029401
- Locations
- π¬π§
Hammersmith Medicines Research (HMR) Limited, London, United Kingdom
π¬π§MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence, Manchester, Greater Mancherster, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath